PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
30-Nov-2020 A new nanoemulsion eye drop formulation of a small molecule RUNX1 inhibitor, a promising experimental therapy for multiple blinding diseases including complications of retinal detachment and eye trauma Joseph Arboleda-Velasquez M.D., Ph.D
30-Nov-2020 Adrenomed closes EUR 22 million equity financing to accelerate development of Adrecizumab (HAM8101) and provides business update Adrenomed AG
30-Nov-2020 Fire Monkey v8 HMW DNA Extraction Delivers 30Gb+ Yield from Sequencing on the ONT MinION B3C newswire
30-Nov-2020 PharmaSGP publishes Q3 Interim Statement 2020 PharmaSGP Holding SE
30-Nov-2020 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics AG Announces Conversion into Vivoryon Therapeutics N.V. Vivoryon Therapeutics AG
30-Nov-2020 Dupixent® (dupilumab) Approved by European Commission as First and Only Biologic Medicine for Children Aged 6 to 11 Years with Severe Atopic Dermatitis Regeneron Pharmaceuticals, Inc.
30-Nov-2020 Ascentage Pharma Enters into an Agreement with University of Michigan to obtain an exclusive license for a MDM2 Degrader using PROTAC Technology Ascentage Pharma
30-Nov-2020 Gannex Appoints Former Takeda Head of Liver Disease Clinical Development Melissa Palmer, MD as Chief Medical Officer Ascletis Pharma Inc.
30-Nov-2020 Gannex Appoints Former Takeda Head of Liver Disease Clinical Development Melissa Palmer, MD as Chief Medical Officer Ascletis Pharma Inc.
28-Nov-2020 Colchicine shows promise as a treatment for at-home COVID-19 patients -- Recruitment of participants in the COLCORONA phase 3 study likely to end in 2020 Montreal Heart Institute
28-Nov-2020 Glenmark to divest select Anti-Allergy brands to Dr Reddy's in Russia, Ukraine, Kazakhstan and Uzbekistan in anticipation of its "Ryaltris" Launch Glenmark Pharmaceuticals Ltd
27-Nov-2020 PharmaSGP Holding SE: Adjustment of full-year forecast 2020 due to expected weaker fourth quarter following COVID-19-related restrictions PharmaSGP Holding SE
27-Nov-2020 Interview Released with Robert Vries, CEO at Hubrecht Organoid Technology speaker at 3D Cell Culture SMi Group
27-Nov-2020 One Nucleus announces finalists of the BioNewsRound Award 2020 Sciad Newswire
27-Nov-2020 MPH Health Care AG: Preliminary IFRS third quarter 2020 results published. Equity (net asset value) amounts to € 194.39 million. This corresponds to € 45.40 per share. MPH Health Care AG
27-Nov-2020 Nanoform Finland Plc, Interim Report January - September 2020, November 27th, 2020 at 08:00 a.m. Finnish time Nanoform
27-Nov-2020 European Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations Merck
26-Nov-2020 Medios AG: Sales increase to more than €1 billion through acquisition of Cranach Pharma GmbH Medios AG
26-Nov-2020 Medios AG acquires Cranach Pharma GmbH; issue of 4,180,000 new Medios shares; significant increase in sales expected in 2021 to over €1 billion Medios AG
26-Nov-2020 Asklepios Kliniken: Consolidated net operating income impacted by continuing coronavirus pandemic Asklepios Kliniken